RMD
ResMed Inc. NYSE Listed Jun 2, 1995$188.63
After hrs
$188.63
+0.00%
Mkt Cap $27.4B
52w Low $180.27
7.4% of range
52w High $293.81
50d MA $207.91
200d MA $242.98
P/E (TTM)
19.6x
EV/EBITDA
14.1x
P/B
4.6x
Debt/Equity
0.1x
ROE
22.9%
P/FCF
16.7x
RSI (14)
35.30
ATR (14)
$5.61
Beta
0.93
50d MA
$207.91
200d MA
$242.98
Avg Volume
1.5M
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
9001 Spectrum Center Boulevard · San Diego, CA 92123 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 2.79 | 2.86 | +2.5% | 213.81 | -3.7% | -4.1% | +2.2% | -0.7% | +0.8% | -1.3% | — |
| Jan 29, 2026 | AMC | 2.74 | 2.81 | +2.6% | 257.61 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% | — |
| Oct 30, 2025 | AMC | 2.51 | 2.55 | +1.6% | 252.26 | +0.9% | -2.1% | +0.8% | -1.0% | -0.5% | +1.8% | — |
| Jul 31, 2025 | AMC | 2.55 | 2.55 | +0.0% | 271.94 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% | — |
| Apr 23, 2025 | AMC | 2.38 | 2.37 | -0.4% | 214.36 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% | — |
| Jan 30, 2025 | AMC | 2.32 | 2.43 | +4.7% | 257.65 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% | — |
| Oct 24, 2024 | AMC | 2.04 | 2.20 | +7.8% | 239.05 | +8.8% | +7.1% | -3.6% | -1.0% | -0.6% | -0.2% | — |
| Aug 1, 2024 | AMC | 2.07 | 2.08 | +0.5% | 214.56 | -2.1% | +4.2% | -3.6% | +1.5% | -3.6% | +1.5% | — |
| Apr 25, 2024 | AMC | 1.91 | 2.13 | +11.5% | 183.42 | +10.7% | +18.9% | -0.4% | -1.5% | +0.5% | +1.5% | — |
| Jan 24, 2024 | AMC | 1.81 | 1.88 | +3.9% | 171.78 | +10.4% | +8.5% | +2.0% | +0.6% | +0.1% | -0.6% | — |
| Oct 26, 2023 | AMC | 1.62 | 1.64 | +1.2% | 138.73 | +4.4% | -2.9% | +2.1% | +2.7% | +4.2% | +2.0% | — |
| Aug 3, 2023 | AMC | 1.69 | 1.60 | -5.3% | 219.95 | -9.8% | -18.5% | +4.1% | -4.0% | -1.3% | +0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 | Morgan Stanley | Downgrade | Overweight → Equal-Weight | $230 | $193.94 | $190.00 | -2.0% | -3.9% | — | — | — | — |
| May 1 | RBC Capital | Maintains | Outperform → Outperform | — | $213.81 | $206.00 | -3.7% | -4.1% | +2.2% | -0.7% | +0.8% | -1.3% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $213.81 | $206.00 | -3.7% | -4.1% | +2.2% | -0.7% | +0.8% | -1.3% |
| Apr 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $219.85 | $219.13 | -0.3% | +1.0% | -2.2% | -2.4% | +0.9% | -4.1% |
| Apr 9 | Citigroup | Maintains | Buy → Buy | — | $230.70 | $227.99 | -1.2% | -1.2% | +0.4% | +0.6% | +0.2% | -0.8% |
| Feb 2 | Citigroup | Maintains | Buy → Buy | — | $258.31 | $257.18 | -0.4% | -1.4% | -1.3% | +4.6% | +1.5% | +1.7% |
| Jan 30 | RBC Capital | Maintains | Outperform → Outperform | — | $257.61 | $251.03 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% |
| Jan 30 | Stifel | Maintains | Hold → Hold | — | $257.61 | $251.03 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% |
| Jan 30 | Piper Sandler | Maintains | Neutral → Neutral | — | $257.61 | $251.03 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% |
| Jan 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $257.61 | $251.03 | -2.6% | +0.3% | -1.4% | -1.3% | +4.6% | +1.5% |
| Dec 18 | Stifel | Maintains | Hold → Hold | — | $245.94 | $246.10 | +0.1% | -1.4% | +1.0% | +0.7% | -0.8% | -0.1% |
| Dec 16 | Baird | Downgrade | Outperform → Neutral | — | $253.07 | $248.01 | -2.0% | -2.3% | -0.6% | -1.4% | +1.0% | +0.7% |
| Nov 3 | Baird | Maintains | Outperform → Outperform | — | $246.88 | $247.54 | +0.3% | +0.8% | -1.0% | -0.5% | +1.8% | +0.7% |
| Oct 31 | Mizuho | Maintains | Outperform → Outperform | — | $252.26 | $254.51 | +0.9% | -2.1% | +0.8% | -1.0% | -0.5% | +1.8% |
| Oct 31 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $252.26 | $254.51 | +0.9% | -2.1% | +0.8% | -1.0% | -0.5% | +1.8% |
| Oct 31 | RBC Capital | Maintains | Outperform → Outperform | — | $252.26 | $254.51 | +0.9% | -2.1% | +0.8% | -1.0% | -0.5% | +1.8% |
| Oct 21 | Morgan Stanley | Maintains | Overweight → Overweight | — | $271.41 | $268.02 | -1.2% | -1.2% | -0.6% | -0.5% | -2.2% | -0.1% |
| Aug 1 | UBS | Maintains | Buy → Buy | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | RBC Capital | Maintains | Outperform → Outperform | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | Stifel | Maintains | Hold → Hold | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | Piper Sandler | Maintains | Neutral → Neutral | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | Mizuho | Maintains | Outperform → Outperform | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Aug 1 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $271.94 | $281.90 | +3.7% | +2.7% | +4.4% | -2.2% | -1.6% | -0.1% |
| Jul 16 | RBC Capital | Upgrade | Sector Perform → Outperform | — | $252.01 | $253.77 | +0.7% | +0.9% | +0.9% | +0.6% | +1.2% | +2.4% |
| Jul 16 | Mizuho | Maintains | Outperform → Outperform | — | $252.01 | $253.77 | +0.7% | +0.9% | +0.9% | +0.6% | +1.2% | +2.4% |
| Apr 24 | JP Morgan | Maintains | Overweight → Overweight | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 24 | UBS | Maintains | Buy → Buy | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 24 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 24 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 24 | Piper Sandler | Maintains | Neutral → Neutral | — | $214.36 | $233.19 | +8.8% | +10.1% | -0.1% | -0.7% | +1.5% | -0.5% |
| Apr 21 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $212.91 | $211.62 | -0.6% | -1.0% | +1.5% | +0.1% | +10.1% | -0.1% |
| Mar 5 | Stifel | Maintains | Hold → Hold | — | $231.48 | $227.71 | -1.6% | -3.3% | +0.5% | +3.3% | +1.8% | -4.6% |
| Mar 5 | Citigroup | Upgrade | Neutral → Buy | — | $231.48 | $227.71 | -1.6% | -3.3% | +0.5% | +3.3% | +1.8% | -4.6% |
| Jan 31 | JP Morgan | Maintains | Overweight → Overweight | — | $257.65 | $258.00 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% |
| Jan 31 | Piper Sandler | Maintains | Neutral → Neutral | — | $257.65 | $258.00 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% |
| Jan 31 | Needham | Maintains | Hold → Hold | — | $257.65 | $258.00 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% |
| Jan 31 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $257.65 | $258.00 | +0.1% | -8.3% | +1.9% | -0.0% | +0.9% | -2.2% |
| Oct 25 | Baird | Maintains | Outperform → Outperform | — | $239.05 | $260.00 | +8.8% | +7.1% | -3.6% | -1.0% | -0.6% | -0.2% |
| Oct 25 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $239.05 | $260.00 | +8.8% | +7.1% | -3.6% | -1.0% | -0.6% | -0.2% |
| Oct 25 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $239.05 | $260.00 | +8.8% | +7.1% | -3.6% | -1.0% | -0.6% | -0.2% |
| Oct 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $244.12 | $245.37 | +0.5% | -2.2% | +0.0% | -0.2% | -1.9% | -0.7% |
| Sep 26 | BofA Securities | Maintains | Buy → Buy | — | $240.75 | $245.83 | +2.1% | +0.8% | -1.5% | +2.1% | -2.2% | +0.0% |
| Sep 18 | Wolfe Research | Downgrade | Peer Perform → Underperform | — | $250.88 | $233.63 | -6.9% | -5.1% | +2.1% | +0.8% | +0.5% | +0.4% |
| Sep 4 | Needham | Downgrade | Buy → Hold | — | $244.90 | $239.90 | -2.0% | -0.1% | +0.0% | +0.0% | +1.9% | +1.3% |
| Aug 2 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $214.56 | $210.00 | -2.1% | +4.2% | -3.6% | +1.5% | -3.6% | +1.5% |
| Aug 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $214.56 | $210.00 | -2.1% | +4.2% | -3.6% | +1.5% | -3.6% | +1.5% |
| Aug 2 | Needham | Maintains | Buy → Buy | — | $214.56 | $210.00 | -2.1% | +4.2% | -3.6% | +1.5% | -3.6% | +1.5% |
| Jul 23 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $207.28 | $207.74 | +0.2% | +1.1% | -1.6% | +1.0% | -5.4% | +5.8% |
| Jun 25 | Oppenheimer | Downgrade | Outperform → Perform | — | $182.20 | $185.07 | +1.6% | +0.9% | +1.5% | +2.7% | -0.1% | -2.3% |
| Jun 24 | Needham | Maintains | Buy → Buy | — | $205.83 | $189.95 | -7.7% | -11.5% | +0.9% | +1.5% | +2.7% | -0.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Farrell Michael J.Dir/Off | Chairman and CEO | Sell | 4,991 | $193.96 | $968K | 466,256 | -1.71% | +0.62% |
| May 7, 2026 | Farrell Michael J.Dir/Off | Chairman and CEO | Sell | 4,991 | $207.82 | $1.0M | 466,223 | +2.53% | +1.12% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 9,466,416 | $2.1B | New | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 7,863,922 | $1.8B | New | Mar 2026 |
| 3 | Morgan Stanley | 5,783,394 | $1.4B | Added | Dec 2025 |
| 4 | Bank Of New York Mellon Corp | 4,925,386 | $1.1B | Added | Mar 2026 |
| 5 | Invesco Ltd. | 1,956,614 | $439M | — | Mar 2026 |
| 6 | Northern Trust Corp | 1,725,693 | $387M | Reduced | Mar 2026 |
| 7 | First Trust Advisors Lp | 1,537,825 | $345M | Added | Mar 2026 |
| 8 | Swedbank Ab | 1,350,234 | $303M | Added | Mar 2026 |
| 9 | Amundi | 1,062,184 | $238M | New | Mar 2026 |
| 10 | Nordea Investment Management Ab | 1,033,381 | $227M | Reduced | Mar 2026 |
| 11 | Bank Of America Corp /de/ | 928,430 | $208M | Added | Mar 2026 |
| 12 | Ubs Group Ag | 726,811 | $163M | Reduced | Mar 2026 |
| 13 | Jpmorgan Chase & Co | 705,147 | $155M | Added | Mar 2026 |
| 14 | Captrust Financial Advisors | 487,861 | $110M | Added | Mar 2026 |
| 15 | Arrowstreet Capital, Limited Partnership | 450,250 | $101M | Added | Mar 2026 |
| 16 | Employees Provident Fund Board | 429,899 | $97M | Added | Mar 2026 |
| 17 | Ilex Capital Partners (Uk) Llp | 413,855 | $93M | Added | Mar 2026 |
| 18 | Marshall Wace, Llp | 381,296 | $86M | New | Mar 2026 |
| 19 | Nuveen, Llc | 379,629 | $85M | Added | Mar 2026 |
| 20 | Aqr Capital Management Llc | 349,840 | $78M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$27.36B
Enterprise Value
$26.90B
P/E (TTM)
19.59x
Forward P/E
17.12x
PEG Ratio
0.72x
P/B
4.64x
P/S
5.40x
P/FCF
16.73x
EV/EBITDA
14.06x
Shares Out
147.3M
Financials (TTM)
Revenue
$5.15B
Net Income
$1.40B
EBITDA
$1.91B
Free Cash Flow
$1.66B
Op Cash Flow
$1.75B
EPS Basic
$9.55
EPS Diluted
$9.51
EPS Forward
$11.02
Gross Margin
59.4%
Op Margin
32.8%
Net Margin
27.2%
Balance Sheet
Total Assets
$8.17B
Total Liab.
$2.21B
Total Equity
$5.97B
Cash
$1.21B
LT Debt
$658.4M
Book Value/Sh
$40.68
Debt/Equity
0.14x
Current Ratio
3.44
Quick Ratio
2.53
Returns & Growth
ROE
22.9%
ROA
17.0%
ROIC
19.6%
Rev Growth YoY
+9.8%
EPS Growth YoY
+37.6%
Price Returns
2W
-5.9%
1M
-10.9%
3M
-25.6%
6M
-25.5%
12M
-22.1%
Technicals
52W High
$293.81
52W Low
$180.27
50d MA
$207.91
200d MA
$242.98
RSI (14)
35.30
ATR (14)
$5.61
Beta
0.93
Avg Volume
1.5M
Dividends
Div Rate
$2.12
Div Yield
1.0%
Frequency
4
Ex-Div Date
Feb 12, 2026
Analyst Price Targets
Consensus
$291.25
High
$345.00
Low
$255.00
Median
$285.50
Data updated apr 26, 2026 11:08pm
· Source: financialmodelingprep.com